These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 384071)

  • 1. Historical development of saralasin.
    Pals DT; Denning GS; Keenan RE
    Kidney Int Suppl; 1979 Mar; (9):S7-10. PubMed ID: 384071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical pharmacology of saralasin.
    Castellion AW; Fulton RW
    Kidney Int Suppl; 1979 Mar; (9):S11-9. PubMed ID: 113608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic studies with saralasin in animals.
    Gavras H; Gavras I; Brunner HR; Liang CS
    Kidney Int Suppl; 1979 Mar; (9):S20-8. PubMed ID: 384069
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [SAR1, ALA8]-Angiotensin II (saralasin): a symposium. Introduction.
    Vaughan ED; Peach MJ
    Kidney Int Suppl; 1979 Mar; (9):S1-2. PubMed ID: 289858
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
    Hollenberg NK; Williams GH
    Kidney Int Suppl; 1979 Mar; (9):S29-35. PubMed ID: 384070
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative studies of the humoral and arterial pressure responses to Sar1-Ala8-, Sar1-Ile8 and Sar1-Thr8-angiotensin II in the trained unanaesthetized dog.
    Bravo EL; Khosla MC; Bumpus FM
    Prog Biochem Pharmacol; 1976; 12():33-40. PubMed ID: 1019168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions with saralasin.
    Mitchell HC; Keeton TK; Pettinger WA
    Kidney Int Suppl; 1979 Mar; (9):S101-6. PubMed ID: 289859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of saralasin to evaluate the function of the brain renin-angiotensin system.
    Reid IA
    Prog Biochem Pharmacol; 1976; 12():117-34. PubMed ID: 1019160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An angiotensin II antagonist with strongly prolonged action.
    Holck M; Bossé R; Fischli W; Gerold H; Escher E
    Biochem Biophys Res Commun; 1989 May; 160(3):1350-6. PubMed ID: 2730646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of angiotensin antagonists in experimental and human renovascular hypertension.
    Maxwell MH
    Adv Nephrol Necker Hosp; 1979; 8():297-319. PubMed ID: 115245
    [No Abstract]   [Full Text] [Related]  

  • 13. Saralasin in human hypertension: the early experience.
    Brunner HR; Laragh JH
    Kidney Int Suppl; 1979 Mar; (9):S36-43. PubMed ID: 289862
    [No Abstract]   [Full Text] [Related]  

  • 14. Rebound hypertensive after sodium nitroprusside prevented by saralasin in rats.
    Delaney TJ; Miller ED
    Anesthesiology; 1980 Feb; 52(2):154-6. PubMed ID: 7352670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of biological effects of three angiotensin II antagonists in sodium depleted hypertensive patients.
    Ogihara T; Nakamaru M; Higaki J; Hata T; Kumagai A; Kumahara Y
    Med J Osaka Univ; 1983 Sep; 34(1-2):21-5. PubMed ID: 6366501
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
    Mimran A; Shaldon S; Barjon P; Mion C
    Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of adrenal arterial infusion of saralasin (P113) on aldosterone secretion.
    Blair-West JR; Coghlan JP; Denton DA; Niall HD; Scoggins BA; Tregear GW
    Prog Biochem Pharmacol; 1976; 12():53-62. PubMed ID: 1019170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will chronic intracerebroventricular saralasin infusion produce selective blockade of brain angiotensin II receptors in the rat?
    Bruner CA; Weaver JM; Fink GD
    J Pharmacol Exp Ther; 1983 Jul; 226(1):13-8. PubMed ID: 6306220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of saralasin on blood pressure, plasma renin and plasma noradrenaline in hypertensive patients].
    Bönner G; Lang R; Hummerich W; Helber A; Meurer KA; Wambach G; Kaufmann W
    Med Welt; 1980 Sep; 31(38):1362, 1363-5. PubMed ID: 7001167
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of central and peripheral angiotensin blockade in hypertensive rats.
    Mann JF; Phillips MI; Dietz R; Haebara H; Ganten D
    Am J Physiol; 1978 May; 234(5):H629-37. PubMed ID: 645931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.